Default company panoramic image
Moleculera logo cmyk

Moleculera Labs, Inc.

A neuroimmunology diagnostics company focused on changing how medicine is practiced for neuropsychiatric and behavioral disorders

  • Stage $500K in TTM Revenue
  • Industry Healthcare Services
  • Location Oklahoma City, OK, USA
  • Currency USD
  • Founded September 2011
  • Employees 15
  • Incorporation Type C-corp
  • Website moleculeralabs.com

Company Summary

Over 60MM Americans suffer from neuropsychiatric and developmental disorders and are treated with neuropsychiatric drugs, often with little improvement. We identify patients whose symptoms are triggered by an immune dysfunction. When properly diagnosed and treated they have remarkable recoveries. Disorders include PANDAS/PANS, ADD/ADHD, Autism, Anxiety Disorder, OCD and others. We generated over $5.2MM in cumulative revenue on a $5MM investment.

Team

  • Default avatar
    Craig Shimasaki, PhD, MBA
    President & CEO

  • Default avatar
    Madeleine Cunningham, PhD
    Chief Scientific Officer

  • Default avatar
    Fred Hiller
    CFO

  • Shimasaki 20headshot 20v2
    President & CEO

Advisors

Previous Investors

  • Default avatar
    Innovation to Enterprise (i2E)
    Unconfirmed
    Default avatar
    SeedStep Angels and Local Investors
    Unconfirmed
    Default avatar
    Dr. Brian Clevinger, Prolog Ventures
    Managing Director
    Unconfirmed